Tower Research Capital LLC (Trc) Zymeworks Inc. Transaction History

Tower Research Capital LLC (Trc)

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.82 - $7.7 $3,663 - $5,852	760 Added 17.18%	5,184 $27,000
Q1 2022 May 12, 2022	SELL	$6.0 - $16.98 $54,894 - $155,350	-9,149 Reduced 67.41%	4,424 $29,000
Q4 2021 Feb 14, 2022	BUY	$15.19 - $29.33 $87,220 - $168,412	5,742 Added 73.32%	13,573 $222,000
Q3 2021 Nov 15, 2021	BUY	$27.35 - $37.28 $210,458 - $286,869	7,695 Added 5658.09%	7,831 $227,000
Q2 2021 Aug 16, 2021	SELL	$26.5 - $38.23 $208,422 - $300,678	-7,865 Reduced 98.3%	136 $5,000
Q1 2021 May 17, 2021	BUY	$29.83 - $56.81 $238,669 - $454,536	8,001 New	8,001 $253,000
Q3 2020 Nov 16, 2020	SELL	$29.21 - $46.58 $15,831 - $25,246	-542 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$33.67 - $40.0 $18,249 - $21,680	542 New	542 $20,000
Q4 2019 Feb 07, 2020	SELL	$24.84 - $45.46 $14,556 - $26,639	-586 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$22.78 - $29.08 $13,349 - $17,040	586 New	586 $15,000
Q4 2018 Feb 14, 2019	SELL	$10.95 - $15.44 $3,208 - $4,523	-293 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$12.21 - $16.61 $11,318 - $15,397	-927 Reduced 75.98%	293 $5,000
Q2 2018 Aug 15, 2018	BUY	$11.13 - $21.86 $10,106 - $19,848	908 Added 291.03%	1,220 $18,000
Q1 2018 May 15, 2018	SELL	$7.93 - $13.41 $11,530 - $19,498	-1,454 Reduced 82.33%	312 $4,000
Q4 2017 Feb 09, 2018	BUY	$6.87 - $9.19 $10,758 - $14,391	1,566 Added 783.0%	1,766 $14,000
Q3 2017 Nov 14, 2017	BUY	$6.48 - $8.73 $1,296 - $1,746	200	200 $2,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $917M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.